JancsiTech, a precision nuclear medicine specialist based in Shenzhen, has reportedly raised “tens of millions” of renminbi in an angel financing round led by Yuanbio Venture Capital. Existing investor Sequoia Capital China also participated in the round. The proceeds will be directed towards research and development, innovation of intelligent medical devices, and the commercialization of products.
Funding Utilization
The funds will be used to ramp up product commercialization, develop nuclear medicine scenarios, and enhance navigation systems and overall intelligent operating room solutions. This investment underscores JancsiTech’s commitment to advancing precision nuclear medicine and intelligent medical technologies.
Company Background
Founded in 2021, JancsiTech has developed an image modeling platform and a radiation dose simulation platform based on AI, high-performance distributed control systems, and multi-mode perception technologies. These innovations position the company at the forefront of intelligent medical device development, aiming to improve the efficiency and accuracy of nuclear medicine applications.-Fineline Info & Tech
